Differential pharmacology and clinical utility of long-acting bronchodilators in COPD – focus on olodaterol

by Matera MG, Ora J, Cazzola M
Published 2015-12-01

Airflow obstruction: is it asthma or is it COPD?

by Rogliani P, Ora J, Puxeddu E, Cazzola M
Published 2016-11-01

The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis

by Rogliani P, Matera MG, Ora J, Cazzola M, Calzetta L
Published 2017-12-01

The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis [Corrigendum]

by Rogliani P, Matera MG, Ora J, Cazzola M, Calzetta L
Published 2018-10-01

Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease

by Ora J, Coppola A, Cazzola M, Calzetta L, Rogliani P
Published 2020-12-01

New Avenues for Phosphodiesterase Inhibitors in Asthma

by Matera MG, Ora J, Cavalli F, Rogliani P, Cazzola M
Published 2021-03-01

An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary Disease

by Cazzola M, Ora J, Cavalli F, Rogliani P, Matera MG
Published 2021-08-01